Innova Captab

Innova Captab

863.90
+3.05
(0.35%)
ann
There are new updates from the company22 hours ago
Viewcross
right
Market Cap
4,943.66 Cr
EPS
22.41
PE Ratio
37.99
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
1,260.00
52 Week Low
662.00
PB Ratio
5.14
Debt to Equity
0.33
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
Innova Captab Reports 19% Revenue Growth to ₹352 Crores in Q1 FY26, Jammu Plant Contributes ₹60 CroresAug 13, 2025
Innova Captab Limited reported consolidated revenue of ₹351.5 crores for Q1 FY26, marking 19% year-on-year growth despite API price declines. EBITDA increased 28% to ₹56.6 crores with margins improving to 16.1%. The company reorganized operations into two verticals: CDMO business (71% of revenue at ₹249.5 crores, 8% growth) and branded generics (59% growth to ₹101.2 crores). The new Jammu facility, commercialized in January 2025 with ₹480 crore investment, generated ₹60 crores revenue in the quarter and is approaching operational breakeven. Management expects the facility to reach ₹100 crore quarterly revenue for PAT breakeven. API prices declined up to 20% in certain categories, particularly affecting anti-infective segments. The company maintains partnerships with over 300 global pharmaceutical companies across 3,700 products.
neutral
Innova Captab Makes Earnings Call Recording Available for Quarter Ended June 30, 2025Aug 08, 2025
Innova Captab Limited has made the audio recording of its earnings call available on the company's website. The call discussed the unaudited financial results for the quarter ended June 30, 2025, and was conducted on August 8, 2025, at 4:00 PM IST through digital means with analysts and investors. The recording can be accessed at https://www.innovacaptab.com/audio/Recording. The company notified both BSE and NSE about the availability of this recording.
positive
Innova Captab Limited's Board approved unaudited financial results for the quarter ended June 30, 2025. On a consolidated basis, the company reported revenue from operations of ₹3,515.42 million compared to ₹2,942.70 million in the same quarter last year, representing significant growth. Profit for the period increased to ₹310.15 million from ₹294.77 million year-over-year. Basic and diluted earnings per share stood at ₹5.42 versus ₹5.15 in the corresponding quarter. On a standalone basis, revenue from operations reached ₹2,869.79 million against ₹2,268.32 million in the prior year quarter, with profit rising to ₹202.95 million from ₹223.36 million. The Board also approved the purchase of land property, with detailed terms to be disclosed upon execution of the final sale agreement. The company operates in the drugs and pharmaceutical products segment and includes subsidiaries Univentis Medicare Limited, Sharon Bio-Medicine Limited, and Univentis Foundation.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,620.20
#1 3,88,740.25
33.69
#1 54,729.00
9.71
#1 10,980
-19.84
49.41
6,051.50
1,60,648.31
70.16
9,712.00
18.67
2,191
26.74
46.47
1,559.60
1,25,970.11
23.34
28,409.50
7.12
5,291
9.88
51.03
3,548.30
1,20,090.60
59.22
11,539.40
6.99
1,911
19.91
42.91
1,311.40
1,09,445.65
#1 19.25
33,741.20
16.73
5,725
1.26
60.11
2,570.20
1,06,079.54
56.09
12,744.20
#1 20.90
2,007
-18.14
53.12
1,033.80
1,04,024.47
22.34
23,511.00
18.55
4,615
2.60
62.88
2,031.20
92,763.98
25.33
22,909.50
13.74
3,306
#1 51.64
68.18
30,970.00
65,809.09
45.31
6,684.70
9.64
1,414
11.55
39.16
5,472.50
65,431.95
28.96
13,458.30
3.70
2,216
21.39
70.33
Forecast
Actual
Growth Rate
Revenue Growth
14.80 %
Net Income Growth
36.06 %
Cash Flow Change
-56.38 %
ROE
17.80 %
ROCE
-1.26 %
EBITDA Margin (Avg.)
3.41 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
217
244
245
244
234
286
305
268
296
320
321
318
356
Expenses
197
211
208
214
202
243
258
225
252
269
270
267
299
EBITDA
21
33
37
29
32
44
47
44
44
52
51
51
57
Operating Profit %
9 %
13 %
14 %
11 %
13 %
14 %
15 %
15 %
14 %
16 %
15 %
15 %
15 %
Depreciation
3
3
3
3
3
5
5
3
5
5
5
10
11
Interest
3
5
6
5
5
9
7
1
0
0
0
2
3
Profit Before Tax
15
25
28
21
25
30
35
40
39
47
46
39
43
Tax
2
6
9
4
7
7
10
11
10
12
11
10
12
Net Profit
13
19
20
17
18
23
25
29
30
35
34
30
31
EPS in ₹
108.91
3.91
4.08
3.59
3.67
4.77
4.39
5.02
5.15
6.12
5.97
5.17
5.42

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
223
245
370
576
704
1,321
1,580
Fixed Assets
79
73
79
183
183
358
830
Current Assets
143
171
271
379
443
580
696
Capital Work in Progress
0
0
7
0
22
341
23
Investments
0
0
0
0
0
0
0
Other Assets
145
172
283
392
500
622
728
Total Liabilities
223
245
370
576
704
1,321
1,580
Current Liabilities
112
120
215
295
278
266
353
Non Current Liabilities
28
14
10
72
150
225
268
Total Equity
83
110
145
209
277
831
959
Reserve & Surplus
71
98
133
197
229
774
902
Share Capital
12
12
12
12
48
57
57

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
2
3
-5
3
8
4
Investing Activities
-9
-6
-20
-188
-91
-499
-152
Operating Activities
19
31
42
59
67
146
64
Financing Activities
-9
-23
-19
125
27
361
92

Share Holding

% Holding
Jun 2022
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
69.75 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
FIIs
0.00 %
0.00 %
0.00 %
1.94 %
1.19 %
1.01 %
0.74 %
0.34 %
0.23 %
DIIs
0.00 %
11.73 %
4.98 %
20.77 %
21.23 %
20.61 %
19.96 %
19.76 %
19.67 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
32.10 %
32.29 %
25.47 %
25.80 %
26.00 %
26.96 %
27.62 %
27.71 %
Others
30.25 %
5.26 %
11.83 %
0.91 %
0.88 %
1.48 %
1.45 %
1.37 %
1.49 %
No of Share Holders
7
1,39,154
1,39,154
39,396
35,115
32,254
36,692
39,996
41,014

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Sept 2024 692.15 803.70
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 741.45 842.70
05 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Feb 2025 895.70 1,008.00
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2025 844.75 923.15
31 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2025 844.30 918.80
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 900.00 927.05

Announcements

Pursuant To Regulation 30 Read With Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) We Hereby Inform You That M/S. CARE Ratings Limited A Credit Rating Agency Has Revised The Cre22 hours ago
Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (The Listing Regulations).Aug 21, 2025
Pursuant To The Regulation 30 (Read With Part A Of Schedule III) And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) We Hereby Inform That The Company Has Successfully Completed Aug 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 07, 2025
Outcome Of The Board Meeting Held Today I.E. 07Th August 2025Aug 07, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. 07Th August 2025Aug 07, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 31, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Consideration Of Unaudited (Standalone And Consolidated) Financial Results For The Quarter EndJul 30, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportJul 25, 2025
Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Jul 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 05, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jul 04, 2025
Reg. 34 (1) Annual Report.Jul 04, 2025
The 21St Annual General Meeting (AGM) Of The Members Of Innova Captab Limited Will Be Held On Thursday 31St July 2025 At 11:00 A.M. (IST) Through Video Conferencing/Other Audio Visual Means (VC/OAVM) In Accordance With The Relevant Circulars Issued By MinJul 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 02, 2025
Closure of Trading WindowJun 25, 2025
Gift Of SharesJun 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 26, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 20, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2025
Shifting Of Registered OfficeMay 19, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 19, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. 19Th May 2025May 19, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Consideration Of Audited Financial Results For The Quarter And Year Ended March 31 2025.May 12, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportApr 25, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 12, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 14, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 13, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 06, 2025
Integrated Filing (Financial)Feb 05, 2025

Technical Indicators

RSI(14)
Neutral
38.97
ATR(14)
Less Volatile
26.48
STOCH(9,6)
Oversold
6.07
STOCH RSI(14)
Oversold
2.56
MACD(12,26)
Bearish
-6.19
ADX(14)
Weak Trend
22.78
UO(9)
Bullish
29.41
ROC(12)
Downtrend And Accelerating
-4.57
WillR(14)
Oversold
-93.27

Mutual Fund Holdings